ARDIGEN
LIVE

Serial Number

99483814

Owner

Ardigen S.A.

Attorney

Alexandra MacKay

Filing Date

Nov 6, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ARDIGEN Trademark

Serial Number: 99483814

ARDIGEN is a trademark filed by Ardigen S.A. on November 6, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently pending registration.

Owner Contact Info

Ardigen S.A.

ul. Leona Henryka Sternbacha 1
Krakow 30-394 , PL

Entity Type: 99

Trademark Details

Filing Date

November 6, 2025

Registration Date

Not Registered

Goods & Services

Licensing of intellectual property and copyrights

Downloadable and recorded computer software for bioinformatics, biomedical data analysis and life science research; Downloadable and recorded computer software for medical and biomedical image analysis; Downloadable and recorded software for clinical trials, drug manufacturing and drug development; Computer software platforms, recorded, for bioinformatics and for biomedical data analysis; Downloadable computer software for molecular research, drug design and molecular structure prediction; Downloadable computer software for the analysis of biological and chemical activity; Downloadable computer software for the analysis, interpretation and integration of the biomedical data; Downloadable computer software for identifying and validating therapeutic targets; Downloadable databases in the fields of bioinformatics, biomedicine, life science and molecular research; Computer programs, downloadable, for database management; Downloadable computer programs for enabling access, browsing, and searching of databases; Downloadable computer software using artificial intelligence (AI) for the analysis, processing, and interpretation of biomedical and bioinformatics data; Downloadable computer software using artificial intelligence (AI) in the field of big data for bioinformatics and biomedical data analysis; None of the aforementioned goods being in direct relation with diagnostics of diseases or detection of contaminants

Scientific study and research in the fields of medicine and biomedicine; Industrial and scientific research services in the fields of biotechnology, biomedicine, bioinformatics, life sciences, molecular science, drug discovery, drug development and drug manufacturing; Scientific analysis of biomedical data for scientific research purposes; Scientific and technological services, namely, scientific research services for others in the fields of biotechnology, bioinformatics, drug discovery, drug manufacturing and drug development; scientific and technological services, namely, medical and biomedical data analysis for research purposes in the fields of biotechnology, bioinformatics, drug discovery, drug manufacturing, and drug development; scientific and technological services, namely, design and development of artificial intelligence (AI) software models in the fields of biotechnology, bioinformatics, drug discovery, drug manufacturing, and drug development; development and optimization of software using computational tools for drug discovery, drug development and drug manufacturing; Technological research in the field of artificial intelligence, machine learning, and computational science for use in drug discovery, drug manufacturing and drug development; Computer programming and design and development of computer software, algorithms, and artificial intelligence models, all for use in the fields of biotechnology, bioinformatics, biomedical research and drug discovery, drug manufacturing and drug development; Installation, repair, updating and maintenance of computer software all for use in the fields of biotechnology, bioinformatics, biomedical research and drug discovery, drug manufacturing and drug development; Software as a service [SaaS] services featuring software for management, visualization and analyzing of biomedical data, in drug discovery, drug development and drug manufacturing process including AI model development; Platform as a service [PaaS] services featuring software for management, visualization and analyzing of biomedical data in drug discovery, drug development and drug manufacturing process, including AI model development; Infrastructure as a service [IaaS] services, namely, hosting software for management, visualization and analyzing of biomedical data in drug discovery, drug development and drug manufacturing process, and AI model development; Bioinformatics services, namely, analysis and interpretation of biological, biomedical data for scientific research purposes; Designing and developing software systems for collecting, storing, and analyzing data in the fields of biomedical research, drug discovery, drug development and drug manufacturing; designing and developing software systems for collecting, storing, and analyzing large-scale biomedical data sets; research services in the nature of design, development, curation, and management of databases of standardized biomedical and pharmaceutical datasets; Providing non-downloadable computer software namely, software for bioinformatics, biotechnology, and biomedicine and drug discovery, drug development and drug manufacturing; design of non-downloadable computer databases in the fields of bioinformatics, biotechnology, biomedicine, drug discovery, drug manufacturing and drug development; none of the aforementioned services being in direct relation with diagnostics of diseases or detection of contaminants

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 12, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 12, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 12, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Nov 6, 2025 MAFR
NEW APPLICATION ENTERED
Nov 6, 2025 NWAP